Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margie O'Leary

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Urologic Nursing|October 19, 2010
Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disordersMargie O'Leary, Mary Dierich
Urology|January 26, 2005
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethraChristopher P Smith, Jun Nishiguchi, Margie O'Leary, et al.
Multiple Sclerosis International|October 29, 2013
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosisDavid J Levinthal, Ambreen Rahman, Salman Nusrat, et al.
The Journal of Urology|January 10, 2004
Can higher doses of oxybutynin improve efficacy in neurogenic bladder?Nelson Bennett, Margie O'Leary, Ankur S Patel, et al.
The Journal of Spinal Cord Medicine|June 28, 2003
Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injuryMargie O'Leary, Janet R Erickson, Christopher P Smith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2004
Bladder and sexual function among women with multiple sclerosisDiane Borello-France, Wendy Leng, Margie O'Leary, et al.
Urologic Nursing|March 14, 2008
Test-retest reliability of the Urge-Urinary Distress Inventory and Female Sexual Function Index in women with multiple sclerosisDiane Borello-France, Jodi Dusi, Margie O'Leary, et al.
The Journal of Spinal Cord Medicine|March 3, 2004
Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trialJang Hwan Kim, David A Rivas, Patrick J Shenot, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Urologic Nursing|October 19, 2010
Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disordersMargie O'Leary, Mary Dierich
Urology|January 26, 2005
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethraChristopher P Smith, Jun Nishiguchi, Margie O'Leary, et al.
Multiple Sclerosis International|October 29, 2013
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosisDavid J Levinthal, Ambreen Rahman, Salman Nusrat, et al.
The Journal of Urology|January 10, 2004
Can higher doses of oxybutynin improve efficacy in neurogenic bladder?Nelson Bennett, Margie O'Leary, Ankur S Patel, et al.
The Journal of Spinal Cord Medicine|June 28, 2003
Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injuryMargie O'Leary, Janet R Erickson, Christopher P Smith, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 26, 2004
Bladder and sexual function among women with multiple sclerosisDiane Borello-France, Wendy Leng, Margie O'Leary, et al.
Urologic Nursing|March 14, 2008
Test-retest reliability of the Urge-Urinary Distress Inventory and Female Sexual Function Index in women with multiple sclerosisDiane Borello-France, Jodi Dusi, Margie O'Leary, et al.
The Journal of Spinal Cord Medicine|March 3, 2004
Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trialJang Hwan Kim, David A Rivas, Patrick J Shenot, et al.
Pageof 1